| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/31/2002 | WO2001064870A3 Mutated cyclin g1 protein |
| 01/31/2002 | WO2001062940A3 New phosphodiesterase type 7b |
| 01/31/2002 | WO2001049243A3 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001031343A3 Diagnosis and therapy of cancer using sgp28-related molecules |
| 01/31/2002 | WO2001008634A3 Polynucleotide encoding a human serine protease |
| 01/31/2002 | WO2000062794A9 A non-immunosuppressive process for inducing acceptance of incompatible transplants |
| 01/31/2002 | WO2000059941A9 Purposeful movement of human migratory cells away from an agent source |
| 01/31/2002 | WO2000047219A3 Methods and reagents for treating glucose metabolic disorders |
| 01/31/2002 | US20020013957 Genetically engineering swine embryos; culture swine embryos, translocate nucleus to another swine embryo, activate oocyte, monitor embryo development |
| 01/31/2002 | US20020013286 Administering the adenoviral gene transfer vector (exogenous) encoding a gene product to a muscle and the vector is neutralized outside of the muscle by systemic neutralizing antibodies; using a chimeric coat protein for cell entry |
| 01/31/2002 | US20020013279 Hematopoietic stimulation |
| 01/31/2002 | US20020013270 Administering a microbiocide to inhibit or eliminate at least one symptom of the disorder; also using a probiotic mixture including a replenishing gastrointestinal microbe; anxiolytic agents; autism; psychosis; attention deficit |
| 01/31/2002 | US20020013267 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 01/31/2002 | US20020013264 Glycosylaminoglycan (GAG) chains chemically modified with a carbodiimide such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide |
| 01/31/2002 | US20020012995 Negative-sense RNA virus vector for nerve cell |
| 01/31/2002 | US20020012993 Improved immortalized human skin cell lines and novel serum-free medium useful for the production thereof |
| 01/31/2002 | US20020012957 Plasma-like solution |
| 01/31/2002 | US20020012954 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 01/31/2002 | US20020012903 Separating neuronal pluripotent stem cells from mixed sample of cells; transform cells, express marker, recover cells expressing marker |
| 01/31/2002 | US20020012714 Combined marine and plant extract compositions |
| 01/31/2002 | US20020012709 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 01/31/2002 | US20020012667 Method for preventing allograft rejection |
| 01/31/2002 | US20020012666 Administering to animal an egg product wherein the egg product is obtained from an egg-producing animal which has been hyperimmunized with an immunogenic vaccine |
| 01/31/2002 | US20020012661 Methods for introducing genes into mammalian subjects |
| 01/31/2002 | US20020012659 Product containing healthful component and process for preparing the same |
| 01/31/2002 | US20020012657 Method for in vitro preconditioning of myoblasts before transplantation |
| 01/31/2002 | US20020012655 Administering to or transplanting into least one cell or tissue obtained from cloned ungulate animal or embryo for therapy |
| 01/31/2002 | US20020012653 Has ability for self-regeneration in a culture medium |
| 01/31/2002 | US20020012637 Administering to the oral cavity of a human or animal one or more lactic bacteria that are not part of resident microflora of mouth, that are low acidifying, and that are capable of adhering directly to pellicle of teeth |
| 01/31/2002 | US20020011452 Container having connecting line for receiving blood, filter for removing leukocytes |
| 01/31/2002 | DE10053783A1 Modifying antigen-presenting cells, useful e.g. in antitumor vaccines, by transfer to them of antigen-containing membrane fragments from diseased cells |
| 01/31/2002 | DE10035231A1 Mitochondrial substitution therapy in humans or animals, especially for treatment of myocardial disease or viral infections, by administration of pure mitochondrial preparation obtained from cell cultures or tissues |
| 01/31/2002 | DE10031179A1 Introducing active molecules into the nucleus of eukaryotic cells, useful for transfection and gene therapy, by applying controlled electrical pulse |
| 01/31/2002 | CA2429502A1 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 01/31/2002 | CA2417188A1 Bacteriophage having multiple host range |
| 01/31/2002 | CA2416682A1 Stem cell-like cells |
| 01/31/2002 | CA2416676A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | CA2416544A1 Mu-conopeptides |
| 01/31/2002 | CA2416488A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | CA2416408A1 Methods for therapy of neurodegenerative disease of the brain |
| 01/31/2002 | CA2416404A1 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 01/31/2002 | CA2416358A1 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type i interferons |
| 01/31/2002 | CA2415862A1 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma |
| 01/31/2002 | CA2413851A1 Modified virus having an altered tropism |
| 01/31/2002 | CA2412544A1 Polypeptide delivery ii-2 |
| 01/31/2002 | CA2354331A1 Composition and method for treatment of gastrointestinal disorders, hyperlipidemia, autoimmune diseases and obesity |
| 01/30/2002 | EP1176200A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances |
| 01/30/2002 | EP1176189A1 Stem cell-like cells |
| 01/30/2002 | EP1175888A2 Topical compositions comprising glycosylated hydroxystilbenes and their uses |
| 01/30/2002 | EP1175616A1 Methods for the diagnosis and treatment of metastatic prostate tumors |
| 01/30/2002 | EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 01/30/2002 | EP1175491A1 Recombinant protein uk114 and its use in therapy and diagnostics |
| 01/30/2002 | EP1175487A2 Pancreatic progenitor cells, methods and uses related thereto |
| 01/30/2002 | EP1175436A2 Transiently immortalized cells for use in gene therapy |
| 01/30/2002 | EP1175228A1 Gene therapy using tgf-beta |
| 01/30/2002 | EP1175223A2 Methods and compositions for modulating an immune response |
| 01/30/2002 | EP1175221A2 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 01/30/2002 | EP1091746B1 Use of iso-osmotic saline solutions for preparing cerumenolytic medicines |
| 01/30/2002 | EP0668913B1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 01/30/2002 | EP0497922B1 Infective protein delivery system |
| 01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2002 | CN1333830A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 01/30/2002 | CN1333818A Bioengineered tissue constructs and method for producing and using them |
| 01/30/2002 | CN1333698A Combination chemotherapy |
| 01/30/2002 | CN1333691A Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 01/30/2002 | CN1333689A Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 01/30/2002 | CN1333688A Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 01/30/2002 | CN1333339A Polytype gene of MXA protein and application thereof |
| 01/30/2002 | CN1333338A Papilloma pseudovirus and process for preparing same |
| 01/30/2002 | CN1333296A Process for preparing high-purity pyretogenless substrateless hematoglobin for red blood cell substitute |
| 01/30/2002 | CN1333056A Medicine for treating gastropathy and preparation process thereof |
| 01/30/2002 | CN1333054A Medicine for relieving cough and asthma |
| 01/30/2002 | CN1333051A Medicine for preventing and treating cancer and preparation process thereof |
| 01/30/2002 | CN1333036A Hair-growing powder medicine and preparation process thereof |
| 01/30/2002 | CN1333024A Injection for mammary sland recovery |
| 01/30/2002 | CN1333023A Bifidoquater live bacterial chip |
| 01/30/2002 | CN1333022A Turtle oil, trionxy oil, composition containing same and usage thereof |
| 01/30/2002 | CN1333021A Serum preparation with function of resisting tumor and preparation process and use thereof |
| 01/30/2002 | CN1332971A Melatonin milk products |
| 01/30/2002 | CN1078583C Selective process for deacylation of acylated compounds |
| 01/30/2002 | CN1078476C Gastric cancer treating Chinese medicine preparation |
| 01/30/2002 | CN1078475C Traditional Chinese medicine plaster for treating osteoproliferation |
| 01/30/2002 | CN1078473C Medicine for regulating menstruation and arresting bleedingand producing process therefor |
| 01/30/2002 | CN1078471C Health medicine for tonifying kidney and its production process |
| 01/30/2002 | CN1078470C Anti-cancer medicinal composition and its preparing method |
| 01/30/2002 | CN1078449C Multifunctional health rice |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342581 Genetic engineering and expression of polynucleotides and polypeptides; vectors, cells, antibodies for diagnosis and disease treatment |
| 01/29/2002 | US6342383 Reverse transcriptase activity; endogenous retroviruses |
| 01/29/2002 | US6342382 Purified nucleic acid; complementarity; washing follow hybridization; genetic engineering and expression |
| 01/29/2002 | US6342366 Bactericides |
| 01/29/2002 | US6342344 Antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions |
| 01/29/2002 | US6342254 Anti-proliferative preparations |
| 01/29/2002 | US6342252 Removing lipids from the bones by steaming/boiling; milling to form a bone slurry; adding neutral lipase, then protease, then papain, then acidifying said secondary enzymatic decomposed liquid |
| 01/29/2002 | US6342236 Cosmetic products compatible with cutaneous ecology |
| 01/29/2002 | US6342216 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 01/29/2002 | US6342157 Device and method for concentrating plasma |
| 01/29/2002 | CA2194555C Implanted device containing tumor cells for the treatment of cancer |
| 01/28/2002 | CA2354107A1 Topical compounds including glucosyl hydroxystilbenes and uses |